Evotec SE (EVO) Preferred Shares (2025 - 2026)
Evotec SE's (EVO) quarterly Preferred Shares came in at $1.7 million in Q1 2026, up 0.61% quarter-over-quarter from $1.7 million in Q4 2025.
Evotec SE (EVO) Preferred Shares (2025 - 2026) Analysis & Trends
Evotec SE has disclosed Preferred Shares across 2 years of filings, most recently posting $1.7 million for Q1 2026.
- Preferred Shares for Q1 2026 came in at $1.7 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 million (changed N/A YoY), and the FY2025 annual result was $1.7 million, changed N/A from the prior year.
- Preferred Shares came in at $1.7 million for Q1 2026 at Evotec SE, up from $1.7 million in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $1.7 million in Q1 2026 to a low of $1.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Evotec SE | 583.10 Mn | 582.58 Mn | - | 1.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.71 Mn |
| Dec 31, 2025 | 1.70 Mn |